Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait in Patients With Cerebellar Ataxia Gene
NCT ID: NCT02903290
Last Updated: 2025-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2017-01-25
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
STUDY OBJECTIVES: The main objective is to study the relationship between changes in energy expenditure and changes in instability when walking at one year in patients with cerebellar ataxia gene. The secondary objectives are to study, after one year of development, the relationship between fatigue, instability, energy consumption, the number of falls, the severity of ataxia and quality of life.
CONDUCT OF THE STUDY: This is a pilot, multicenter, interventional. The projected duration of patient recruitment will be 12 months and the total number of patients will be included in 15. The duration of participation in this study is 12 months for each patient. The anticipated duration of the study is 30 months. Development of the study: Patients included will perform two sets (S1 and S2) tests a year apart including the evaluation of ataxia according Scale for the assessment and rating of ataxia (SARA); measuring the quality of life through SF36 (The Short Form (36)) Questionnaire; quantifying the severity of fatigue perceived by FSS questionnaire quantifying the severity of physical tiredness by VAS before and after physical activity; quantified analysis of walking on walking track GAITRite® (with score calculation FAP and GVI) before and after physical activity; physical activity like walking on a treadmill (with measurement of maximal voluntary quadriceps by manual dynamometer before and after physical activity to ensure the induction of fatigue). Patients will be provided with a portable device for analyzing gas exchange FitMateMED® (COSMED, Rome, Italy) during walking analyzes GAITRite®.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Training in Ataxia - Individuals With Degenerative Cerebellar Diseases
NCT05002218
Aerobic Exercise, Balance Training, and Ataxia
NCT03745248
Wearable Gait Sensors
NCT06628934
Core Stability Exercises and Hereditary Ataxia
NCT04750850
Ataxia and Exercise Disease Using MRI and Gait Analysis
NCT03701776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cerebellar ataxia
Evaluation ataxia according SARAs; measuring the quality of life through SF36 Questionnaire; quantifying the severity of fatigue perceived by FSS questionnaire quantifying the severity of physical tiredness by VAS before and after physical activity; quantified analysis of walking on walking track GAITRite® (with score calculation FAP and GVI) before and after physical activity; physical activity like walking on a treadmill (with measurement of maximal voluntary quadriceps by manual dynamometer before and after physical activity to ensure the induction of fatigue). Patients will be provided with a portable device for analyzing gas exchange FitMateMED® (COSMED, Rome, Italy) during walking analyzes GAITRite®
Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait
Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait
walking track GAITRite,manual dynamometer, and treadmill
walking track GAITRite,manual dynamometer, and treadmill
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait
Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait
walking track GAITRite,manual dynamometer, and treadmill
walking track GAITRite,manual dynamometer, and treadmill
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with cerebellar syndrome genetically determined or evidence of inheritance;
* Patient walking more than 50 meters independently, with or without technical assistance;
* Patient likely to be followed regularly for at least one year;
* Patient has given written informed consent;
* Patient affiliated to Social Security.
Exclusion Criteria
* Patient with any disease or condition incompatible to the success of the study according to the doctor's judgment;
* Patient not strolling or sauntering only with a third person to help;
* Major person under guardianship;
* People hospitalized without his consent and not protected by law;
* Nobody deprived of liberty;
* Patients speakers.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
SACCONI Sabrina
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Nice
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nice
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-AOI-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.